Does the fact that SGEN has 3.5x the market cap of IMGN and the fact IMGN has using an"armed" antibody (Herceptin) that is already approved for a very large market factor into your comparisons?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.